Skip to main content
. 2021 Jul 27;9:564991. doi: 10.3389/fped.2021.564991

Figure 3.

Figure 3

Levels of tigecycline and polymyxin B in cerebrospinal fuid (CSF) of the patient. (A) CSF tigecycline concentrations were measured with Two-Dimensional High-Performance Liquid Chromatography (2D-HPLC) method. (B) CSF polymyxin B levels were determined using high performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Red circle represents the day of ITH polymyxin B treatment.